Back

Autism spectrum disorder: understanding the impact of SNPs on biological pathways in the fetal and adult cortex.

Golovina, E.; Fadason, T.; Lints, T.; Walker, C.; Vickers, M. H.; O'Sullivan, J. M.

2021-03-03 genomics
10.1101/2021.03.03.433667 bioRxiv
Show abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by significant and complex genetic etiology. GWAS studies have identified genetic variants associated with ASD, but the functional impacts of these variants remain unknown. Here, we integrated four distinct levels of biological information (GWAS, eQTL, spatial genome organization and protein-protein interactions) to identify potential regulatory impacts of ASD-associated SNPs (p < 5x10-8) on biological pathways within fetal and adult cortical tissues. We found 80 and 58 SNPs that mark regulatory regions (i.e. expression quantitative trait loci or eQTLs) in the fetal and adult cortex, respectively. These eQTLs were also linked to other psychiatric disorders (e.g. schizophrenia, ADHD, bipolar disorder). Functional annotation of ASD-associated eQTLs revealed that they are involved in diverse regulatory processes. In particular, we found significant enrichment of eQTLs within regions repressed by Polycomb proteins in the fetal cortex compared to the adult cortex. Furthermore, we constructed fetal and adult cortex-specific protein-protein interaction networks and identified that ASD-associated regulatory SNPs impact on immune pathways, fatty acid metabolism, ribosome biogenesis, aminoacyl-tRNA biosynthesis and spliceosome in the fetal cortex. By contrast in the adult cortex, they largely affect immune pathways. Overall, our findings highlight potential regulatory mechanisms and pathways important for the etiology of ASD in early brain development and adulthood. This approach, in combination with clinical studies on ASD, will contribute to individualized mechanistic understanding of ASD development.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Neurodevelopmental Disorders
15 papers in training set
Top 0.1%
10.0%
2
Cell Genomics
162 papers in training set
Top 0.2%
10.0%
3
Translational Psychiatry
219 papers in training set
Top 0.9%
6.8%
4
Biological Psychiatry
119 papers in training set
Top 0.4%
6.8%
5
Molecular Autism
29 papers in training set
Top 0.1%
6.3%
6
Cell Reports
1338 papers in training set
Top 12%
4.1%
7
Scientific Reports
3102 papers in training set
Top 29%
4.1%
8
eLife
5422 papers in training set
Top 26%
3.6%
50% of probability mass above
9
Biology of Sex Differences
29 papers in training set
Top 0.1%
2.9%
10
Human Molecular Genetics
130 papers in training set
Top 1%
1.9%
11
Molecular Psychiatry
242 papers in training set
Top 2%
1.7%
12
Autism Research
32 papers in training set
Top 0.3%
1.7%
13
Frontiers in Genetics
197 papers in training set
Top 5%
1.7%
14
PLOS Genetics
756 papers in training set
Top 9%
1.7%
15
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.3%
1.7%
16
Human Genetics and Genomics Advances
70 papers in training set
Top 0.4%
1.5%
17
npj Genomic Medicine
33 papers in training set
Top 0.5%
1.5%
18
Communications Biology
886 papers in training set
Top 13%
1.3%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.2%
20
The American Journal of Human Genetics
206 papers in training set
Top 3%
1.2%
21
PLOS Computational Biology
1633 papers in training set
Top 20%
1.2%
22
iScience
1063 papers in training set
Top 22%
1.2%
23
Genome Medicine
154 papers in training set
Top 6%
1.2%
24
Genetic Epidemiology
46 papers in training set
Top 0.6%
1.2%
25
Journal of Genetics and Genomics
36 papers in training set
Top 2%
0.9%
26
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.3%
0.9%
27
PLOS ONE
4510 papers in training set
Top 64%
0.9%
28
Briefings in Bioinformatics
326 papers in training set
Top 6%
0.9%
29
Nature Communications
4913 papers in training set
Top 61%
0.8%
30
Genome Research
409 papers in training set
Top 4%
0.8%